Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Germany

European Innovation Council · Running

MiWear Mid-infrared Wearable for Non-invasive biomarker monitoring

Coordinator
Quantune Technologies GmbH, Germany
Runs
1 January 2024 to 30 June 2027
Status
Running
EU funding
€4.0m
Total cost
€4.0m
Partners
6 organisations in 6 countries
Type
European Innovation Council
Grant agreement
101115476

What the project is doing

In the project's own words, from its summary on CORDIS.

Modern medicine has improved dramatically through a better understanding of what causes a condition or what it is correlated to. However, the healthcare system still follows an episodic (reactive) model, where patients only seek medical advice when there are symptoms, which, for certain medical conditions, has proven critically insufficient. In this context, one of the main burdens for our socioeconomic system in Europe by a single disease is without question the metabolic syndrome (MbS).

MbS is prominently visible in the large and ever-growing number of overweight or obese individuals. Yet, its true negative dramatic consequences among others are arteriosclerosis, hereby induced myocardial infarction, and stroke. Several biomarkers such as uric acid, albumin, or ketone bodies correlate with MbS and often indicate different aspects of the metabolic syndrome. The more biomarkers can be measured and quantified with high accuracy, the easier it becomes to make conclusive decisions on the patient’s status.

False negatives as well as false positives can be avoided much better with more parameters – if each of them is measured individually and directly without the need for indirect methods where evaluations are easily overfitted. We provide an alternative approach for the measurement of biomarkers, using a miniatured Mid-Infrared spectrometer, a technology that is only used in laboratories due to its size and cost. The result of the project will be a wearable device to detect biomarkers non-invasively and pain-free in the interstitial fluid in the skin.

For MiWear, we have gathered an impressive consortium combining expert knowledge on biomarkers, optical spectroscopy, laser physics, business management, finances, and the gender dimension of biomarkers. During the project, we will generate opportunities for young researchers, and engage with different stakeholders to ensure maximum outreach of our research and development activities.

Topics

Who is involved

OrganisationCityCountryRole
Quantune Technologies GmbHBerlinGermanyCoordinator
Joanneum Research Forschungsgesellschaft MbhGrazAustriaParticipant
Science&strategy SLVacarissesSpainParticipant
Teknologian Tutkimuskeskus VTT OyEspooFinlandParticipant
Stichting Radboud Universitair Medisch CentrumNijmegenNetherlandsParticipant
Artificial Intelligence Expert SRLCluj NapocaRomaniaParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI